Last updated: February 22, 2023
Sponsor: Genesis Athens Clinic
Overall Status: Active - Recruiting
Phase
2
Condition
Endometriosis
Soft Tissue Infections
Gynecological Infections
Treatment
N/AClinical Study ID
NCT05205993
IAI-1
Ages 18-50 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Positive diagnosis of CE following hysteroscopy and endometrial biopsy (positivediagnosis is required by both evaluations)
- Signed Informed Consent
- 18.5 < BMI < 30
Exclusion
Exclusion Criteria:
- Diagnosed endometriosis or other related Pelvic Inflammatory Disorder (PID)
- Current or previous cancer diagnosis
- Auto-immune or genetic disorders
- Menstrual cycle disorders
Study Design
Total Participants: 90
Study Start date:
January 19, 2021
Estimated Completion Date:
April 30, 2024
Study Description
Connect with a study center
Genesis AC
Athens, 15232
GreeceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.